Myrbetriq Alternatives Compared
| Myrbetriq | Oxybutynin | VESIcare |
|
|---|
| Myrbetriq mirabegron | Oxybutynin | VESIcare solifenacin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Myrbetriq may be used to relieve symptoms of overactive bladder in adults such as urinary incontinence and urinary frequency. It may also be used to treat the symptoms of neurogenic detrusor... View more |
Oxybutynin helps to relieve symptoms of an overactive bladder and urinary incontinence but it may cause side effects such as dry mouth and constipation. Prescribed for Urinary Incontinence, Urinary... View more |
Prescribed for Overactive Bladder, Urinary Frequency, Urinary Incontinence. VESIcare may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Urinary Frequency
Urinary Incontinence
Popular Comparisons
|
|||||||||||||||||||||||
| More about Myrbetriq (mirabegron) | More about Oxybutynin | More about VESIcare (solifenacin) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription and OTC |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Myrbetriq has an average rating of 4.8 out of 10 from a total of 246 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 48% reported a negative effect. |
Oxybutynin has an average rating of 6.6 out of 10 from a total of 408 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 25% reported a negative effect. |
VESIcare has an average rating of 5.5 out of 10 from a total of 137 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 37% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Common side effects include: hypertension. See the full Myrbetriq side effects document. |
Commonly reported side effects include: constipation, drowsiness, local pruritus. See the full oxybutynin side effects document. |
Common side effects include: constipation, xerostomia. See the full VESIcare side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Myrbetriq prices |
View all oxybutynin prices |
View all VESIcare prices and generic prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Ditropan XL, Gelnique, Oxytrol, Oxytrol for Women | Other solifenacin brands include: VESIcare LS | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
50 hours |
2.3 hours |
68 hours |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 217 drugs are known to interact with Myrbetriq:
|
A total of 263 drugs are known to interact with oxybutynin:
|
A total of 461 drugs are known to interact with VESIcare:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 28, 2012 |
July 16, 1975 |
November 19, 2004 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.